Cigna Group CI

Cigna Group (CI) used its 2026 Investor Day to roll out a new Lead to One vision, outline a US$3b modernization push, and reaffirm both current guidance and long term growth targets. Cigna Group’s recent Investor Day comes after a period where momentum has cooled, with the share price at US$271.83 and a 90 day share price return down 5.5%, while the 5 year total shareholder return of 46.8% points to a much stronger longer run outcome. Compare Cigna Group’s new long term plan with peers by...

Cigna Group (NYSE:CI) reaffirmed its 2026 outlook and outlined a long-term strategy centered on complex care, technology-enabled personalization and disciplined capital deployment at its 2026 Investor Day. President and CEO Brian Evanko said the company has reshaped its portfolio over the past deca

Cigna Group has delivered a mixed run in recent years, and investors now have to decide whether the current US$275.26 share price lines up with what its earnings justify. The question is whether that price fairly reflects what the business is generating today, rather than just where the stock has traded before. Over the past 5 years the stock has gained about 50.0%, which puts real weight on whether the underlying earnings profile can support that kind of long term outcome. The business...

Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.

Recently, investors focused on Cigna Group’s leadership change as new CEO Brian Evanko began outlining plans for the company’s specialty pharmacy business. This leadership shift matters because specialty pharmacy is a core earnings engine, and any change in its direction could reshape Cigna’s long‑term mix of health services. Next, we’ll examine how Evanko’s emphasis on specialty pharmacy growth could influence Cigna Group’s existing investment narrative around Evernorth and Signature. AI is...

Today, at its Investor Day, The Cigna Group (NYSE: CI) will outline its strategy to improve affordability and personalization across the health care continuum. Enterprise leaders will detail how the Company's deliberately shaped portfolio, differentiated leadership in complex care, and disciplined execution position it to deliver durable growth, robust operating cash flow, and enhanced shareholder returns.

UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.

Cuban believes in Medicare for All, but thinks people need to temper their expectations. He thinks a recently introduced bill is most consumers' best shot for now.

Mark Cuban offers an unconventional way for employers to raise funding if they need it: Change your PBM.

If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

By Exec Edge Editorial Staff Health insurance premiums have climbed for years. Deductibles have climbed right along with them. Yet a growing number of American households are choosing neither, opting instead for a decades-old alternative, which is not health insurance, built around monthly contributions and community values. “People are clearly paying high premiums now,” Liberty […] The post Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Pod

UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.

UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.

CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.

UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.

New research from The Cigna Group (NYSE: CI) finds that volunteering is associated with better health, stronger workplace engagement, and greater connection to community. According to the company's fifth annual Vitality in America report, people who volunteer are nearly twice as likely to report high vitality, a measure of how healthy, connected, and capable a person feels. The research also found that employees who participate in employer-supported volunteer activities are significantly more li